Khiron Life Sciences Corp.: Invitation to the Q4 Virtual Investor Summit
Date
11/9/2021 7:20:24 AM
(MENAFN- Newsfile Corp) Khiron Life Sciences Corp.: Invitation to the Q4 Virtual Investor Summit
Toronto, Ontario--(Newsfile Corp. - November 9, 2021) - Khiron Life Sciences Corp. (TSXV: KHRN) today announced that Alvaro Torres, CEO will be attending the Q4 Virtual Investor Summit.
| Event | Q4 Investor Summit |
| Date | November 16-17th, 2021 |
| Presentation | November 16th at 11:45 AM ET |
| Location | |
About Khiron Life Sciences Corp.
Khiron is a leading vertically integrated international medical cannabis company with core operations in Latin America and Europe. Leveraging wholly-owned medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure to drive prescriptions and brand loyalty with patients worldwide. The Company has a sales presence in Colombia, Peru, Germany, UK, and Brazil and is positioned to commence sales in Mexico. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors.Visit Khiron online at investors.khiron.ca andLinkedin at .
For further information:
Khiron Life Sciences Corp.
Paola Ricardo
4165402970
About the Investor Summit
The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q4 Investor Summit will take place virtually, featuring 80+ companies and over 800 investors, consisting of institutional investors, family offices, and private wealth.
To request complimentary investor registration: please click here: Complimentary Investor Registration
Contact:
Sasha Murray at
MENAFN09112021004218003983ID1103129438
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.